基于吡啶基苯甲酸盐的两个银(Ⅰ)配合物的合成、晶体结构及荧光性质

合成了2个含有吡啶基苯甲酸盐的银(Ⅰ)配合物,即[Ag₂(PPh₃)₂(4,4-pybz)₂(H₂O)₂]_n(1) 和[Ag₂(PPh₃)₂(4,3-pybz)₂]·2CH₃OH(2)(PPh₃=三苯基膦,4, 4-pybz=4-吡啶-4-基-苯甲酸根, 4,3-pybz=4-吡啶-3-基-苯甲酸根),并通过红外光谱、元素分析和荧光光谱进行分析和表征,它们的结构由X射线单晶衍射测定.在不同的溶剂下,2个配合物由AgBF₄、PPh₃和不同的吡啶苯甲酸在氨水作用下,以1:1:1的比例反应而成.在配合物1中,所有的银原子由吡啶基苯甲酸桥连形成一维链状结构.在配合物2中,2个银原子通过2个4-吡啶-3-基-苯甲酸根配体形成双核结构.在荧光光谱中,在发射状态下所有的峰均来源于配体的π-π*跃迁.     

基于吡啶基苯甲酸盐的两个银(Ⅰ)配合物的合成、晶体结构及荧光性质

合成了2个含有吡啶基苯甲酸盐的银(Ⅰ)配合物,即[Ag₂(PPh₃)₂(4,4-pybz)₂(H₂O)₂]_n(1)和[Ag₂(PPh₃)₂(4,3-pybz)₂]·2CH₃OH(2)(PPh₃=三苯基膦,4, 4-pybz=4-吡啶-4-基-苯甲酸根, 4,3-pybz=4-吡啶-3-基-苯甲酸根),并通过红外光谱、元素分析和荧光光谱进行分析和表征,它们的结构由X射线单晶衍射测定。在不同的溶剂下,2个配合物由AgBF₄、PPh₃和不同的吡啶苯甲酸在氨水作用下,以1:1:1的比例反应而成。在配合物1中,所有的银原子由吡啶基苯甲酸桥连形成一维链状结构。在配合物2中,2个银原子通过2个4-吡啶-3-基-苯甲酸根配体形成双核结构。在荧光光谱中,在发射状态下所有的峰均来源于配体的π-π*跃迁。     

柠檬酸改性的H-Beta上2-(4′-乙基苯甲酰基)苯甲酸的脱水反应

 以改性的 H-beta 沸石分子筛为催化剂,代替传统的浓硫酸或发烟硫酸催化剂,使2-(4′-乙基苯甲酰基)苯甲酸脱水闭环生成 2-乙基蒽醌是一条清洁生产路线. 其中柠檬酸改性的 H-beta 催化剂表现出很好的催化性能,可以明显降低反应温度,缩短反应时间. 在柠檬酸改性的 H-beta 催化剂上,当反应温度为529 K, 反应时间为60 min时, 2-(4′-乙基苯甲酰基)苯甲酸的转化率为99.5%, 2-乙基蒽醌的选择性可达97.2%; 而在未经柠檬酸改性的 H-beta 催化剂上,当反应温度为550 K, 反应时间为60 min时, 2-(4′-乙基苯甲酰基)苯甲酸的转化率只有81.6%, 2-乙基蒽醌的选择性为96.4%.     

2-氨基-4-甲氧基氯代苯甲酸的合成研究

以2-氨基-4-甲氧基苯甲酸甲酯为原料,通过氯代反应,再分别通过酯水解反应得到化合物2-氨基-5-氯-4-甲氧基苯甲酸和2-氨基-3-氯-4-甲氧基苯甲酸。其中间体及产物结构经~1H NMR、~(13)C NMR和ESI-MS确证,并考察了最佳氯代反应条件。结果表明:物料配比为n(2-氨基-4-甲氧基苯甲酸甲酯)∶n(NCS)=1∶1. 2,反应溶剂为N,N-二甲基甲酰胺,反应时间为16 h,两种氯代产物2-氨基-5-氯-4-甲氧基苯甲酸甲酯和2-氨基-3-氯-4-甲氧基苯甲酸甲酯收率分别为47%和39%。     

(±)-3-正丁基-4-甲氧基苯酞的合成

以3-羟基苯甲酸为原料,通过中间体(±)-3-羟基-4-甲氧基苯酞合成了(±)-3-正丁基-4-甲氧基苯酞(?)。     

2-{[(2'-氰基联苯基-4-基)甲基]氨基}-3-硝基苯甲酸甲酯的合成

以3-硝基-2-氨基苯甲酸甲酯为原料,经三氟乙酰化、N-烷基化和脱保护反应制得坎地沙坦中间体2-{[(2'-氰基联苯基-4-基)甲基]氨基}-3-硝基苯甲酸甲酯,其结构经~1H NMR,~(13)C NMR和MS(ESI)确证。     

以4-(1-咪唑基)苯甲酸和桥联氯构筑的一维梯状结构的镉配位聚合物的晶体结构和荧光性质

水热条件下以CdCl₂和4-(1-咪唑基)苯甲酸(Himbz)为反应物合成出一个新的具有一维梯子型链状结构的配位聚合物 [Cd(imbz)(Cl)(H₂O)]_n(1), 并分别用元素分析, 红外谱图, 差热分析和X-射线单晶衍射表征该结构。晶体结构分析结果表明:4-(1-咪唑基)苯甲酸离子(imbz)将Cd(Ⅱ)离子连接成一维Z字链, 进而通过桥联氯原子被连接成一维梯状链结构, 荧光谱图表明常温固态下配合物1发射蓝色荧光, 荧光寿命为2.21 ns。     

4-(4-{5-[(二苄胺基甲酰)-甲基]-2-庚基-4-羰基-噻唑-3}-丁基)苯甲酸的合成研究

报道一个新型胰岛素增敏剂4-(4-{5-[(二苄胺基甲酰)-甲基]-2-庚基-4-羰基-噻唑-3}-丁基)苯甲酸的合成方法. 该化合物以对碘苯甲酸为原料, 经过羧基的保护、Heck反应、还原反应、Ing-Mnske反应、噻唑环合成、酰胺制备和羧酸保护基解除等一系列反应, 通过对反应条件的优化, 高产率合成4-(4-{5-[(二苄胺基甲酰)-甲基]-2-庚基-4-羰基-噻唑-3}-丁基)苯甲酸, 并对其中间体对碘苯甲酸叔丁酯的合成方法进行研究.     

基于4-(4-咪唑基-亚甲基氨基)苯甲酸配体配合物的合成及结构

利用不同的方法由配体4-(4-咪唑基-亚甲基氨基)苯甲酸(H₂L)和过渡金属盐反应合成了3个配合物[M(HL)₂(H₂O)₂](M(Ⅱ)=Mn(Ⅱ)(1),Cd(Ⅱ)(2),Cu(Ⅱ)(3)),进行了X-射线单晶衍射等表征。晶体结构解析结果表明：配合物1~3都属于三斜晶系,P1空间群,分子之间通过丰富的氢键相互作用最终形成了三维超分子结构。并且研究了配合物的热稳定性和电化学性质。     

基于4-(4-咪唑基-亚甲基氨基)苯甲酸配体配合物的合成及结构

利用不同的方法由配体4-(4-咪唑基-亚甲基氨基)苯甲酸(H₂L)和过渡金属盐反应合成了3个配合物[M(HL)₂(H₂O)₂](M(Ⅱ)=Mn(Ⅱ)(1),Cd(Ⅱ)(2),Cu(Ⅱ)(3)),进行了X-射线单晶衍射等表征。晶体结构解析结果表明:配合物1~3都属于三斜晶系,P1空间群,分子之间通过丰富的氢键相互作用最终形成了三维超分子结构。并且研究了配合物的热稳定性和电化学性质。     

2－甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（3H）－喹唑啉酮的合成

以2－氨基对苯二甲酸（1）为起始原料，与乙酸酐缩合生成7－羧基乙酰苯邻 甲内酰胺（2）；2和芳胺缩合产生7－羧基－2－甲基－3－芳基－4（3H）－喹唑啉 酮（3）；3和N，N－双环己基碳双亚胺（DCC）加成得到中间体4，4在4－二甲氨基 吡啶（DMAP）催化下和5，5－二甲基－1，3－环己二酮（5）缩合得到目标产物2－ 甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（ 3H）－喹唑啉酮（6）。所得15个新型化合物的结构均经^1H NMR、元素分析确证， 部分化合物经IC／MSD确证。     

Syntheses of Benzoxepinoquinolinone and Benzothiepinoquinolinone

l-Benzoxepino(3, 4-b)quinolin-l3(6H)-one and its halogen,alkyl, alkoxy derivatives Va'-d' and 1-benzothiepino(3,4-b}-quinolin- 13 ( 6H)-one Vf, and its alkyl derivatives Vg, weresynthesized through cyclization of 2-(substituted phenoxymethyl)-3-quinolinecarboxylic acids Va-d and 2-[ (un)substituted phen-ylthiomethyll-3-quinolinecarboxylic acids IVf-g in the presence ofpolyphosphoric acid.The acids IV were obtained from the corresponding ethyl-esters @ whcih were prepared through refluxing ethyl 2-bromo-methyl-3-quinolinecarboxylate(1) with substituted phenol or (un)substituted thiophenol in the presence of NaOEt.The compound Vg, was allowed to react with NBS, KaBH4, NH2OH-HCl to give compounds VII , VIII, and IX, respectively.The structures of 24 new compounds have been confirmed by elemental analysis, IR and 1H NMR.     

Pyridazine Derivatives and Related Compounds,Part 1. Some Reactions with 4-Cyano-5,6-Diphenyl-2,3-Dihydropyridazine-3-One

4-Cyano-5,6-diphenyl-2,3-dihydropyridazine-3-onc 1 reacts with phosphorous oxychloride to give 70% of the corresponding 3-chloro derivative 2. Treating 2 with anthranilic acid in butanol, 4-cyano-2,3-diphenyl-10H-pyridazino[6,1-b]quinoxaline-10-one, 3 was obtained. Compound 1 reacts with phosphorous pentasulphide to give 3-mercapto derivative 4, which was converted by acrylonitrile to S-(2-cyanoethyl)pyridazine derivative 5. Compound 4 reacts with ethyl bromoacetate and with phenacyl bromide gave the corresponding thieno[2,3-c] pyridazine derivatives 8, 9, Alkylation of 1 with ethyl chloroacetate afforded 3-0-carbethoxymethyl derivative 10. Compound 10 reacts with amines (aniline, hydrazine) to give the corresponding amide and acid hydrazide 13, 12 respectively. Hydrolysis of 10 with sodium hydroxide gave the corresponding acid derivative 11. Treating 1 with methyl iodide, 3-0-methyl derivative 14 was obtained, which was converted by ammonium acetate/acetic acid to 3-amino-4-cyano-5,6-diphenyl pyridazine 15. Compound 1 reacts with methyl magnesium iodide gave 4-acetyl derivative 16, which was reacted with hydrazine, phenyl hydrazine and with hydroxylamine to give the substituted I H pyrazolo [3,4-c] pyridazine 17 a,b and isoxazolo [5,4-c] pyridazine 18 derivatives respectively.     

S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲的合成及其iNOS抑制活性

以2-巯基苯并咪唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并咪唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,¹HNMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,其中化合物6b,8d和8f的iNOS抑制活性与阳性对照药氨基胍相当.     

用NaBH4还原3-(3,4-二苄氧基苯基)-2-羟基丙烯酸甲酯

用NaBH4还原3-(3,4-二苄氧基苯基)-2-羟基丙烯酸甲酯得到3-(3,4-二苄氧基苯基)-乳酸甲酯和3,4-二苄氧基苯基-1,2-丙二醇(1)。1的结构经1HNMR,13CNMR和MS确定。     

Synthesis,anti-inflammatory and analgesic activity of 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid derivatives

The title compounds 3a–l have been synthesized by the reaction of thiocarbohydrazide with substituted phenoxy acetic acid to obtained substituted 1,2,4-triazoles (1). Compound 1 was treated with various substituted aromatic aldehydes which results in 4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-2H-1,2,4-triazol-3(4H)-thiones (2a–g), further 2a–g is converted to 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3a–l) derivatives by the reaction with chloroacetic acid. All the newly synthesized compounds were evaluated for in vivo anti-inflammatory and analgesic activities. Among the series 2-[4-(2,4-dichlorobenzylideneamino)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3d), 2-[4-(4-dichlorobenzylideneamino)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3e), 2-[4-(2,4-dichlorobenzylideneamino)-5-[(2,4-dichlorophenoxy)methyl]-4H-1,2,4-triazol-3-yl thio] acetic acid (3j) and 2-[5-[(2,4-dichlorophenoxy)methyl)]-4-(4-chlorobenzylideneamino)-4H-1,2,4-triazol-3-yl thio] acetic acid (3k) showed significant anti-inflammatory activity with P < 0.001 (63.4%, 62.0%, 64.1% and 62.5% edema inhibition, respectively), as compared to the standard drug diclofenac (67.0%) after third hour respectively and also compounds 3j, 3k exhibited significant analgesic activity with P < 0.001 (55.9% and 54.9% protection, respectively) and less ulcerogenic activity as compared with standard drug aspirin (57.8%).     

Direct synthesis of methyl 2-diazo-4-aryl-3-butenoates and their application to the enantioselective synthesis of 4-aryl-4-(1-naphthyl)-2-butenoates

An improved one-flask synthesis of various methyl 2-diazo-4-aryl and 4-heteroaryl-3-butenoates, precursors to donor/acceptor substituted carbenoids, is described. Their Rh₂(S-DOSP)₄ catalyzed reaction with 1-acetoxy-3,4-dihydronaphthalene, via a combined C–H activation/Cope rearrangement pathway followed by elimination of acetic acid affords a highly enantioselective (98–99% ee) entry to methyl 4-aryl- and 4-heteroaryl-4-(1-naphthyl)-2-butenoates.     

4-(N-乙基-3-甲基苯胺基）丁酸甲酯的合成

以γ-丁内酯为起始原料,经开环氯化和醇解反应合成4-氯丁酸甲酯（2）; 2与N-乙基间甲苯胺经亲核取代反应合成了4-(N-乙基-3-甲基苯胺基）丁酸甲酯,纯度97.5%,总收率75.3%,其结构经¹H NMR确证。     

全氟和多氟烷基磺酸的研究 VIII: N-(3'-三氯硅基丙基)-3-氧杂全氟烷基磺酰胺及基衍生物的合成

3-OXaperfluoroalkanesulfonyl fluoride (1) reacted with allylamine to give the corresponding N-allylsulfonamide 2 which on treatment with sodium methoxide and methyl iodide affrded N-methyl-N-allyl-3 -oxaperfluoroalkanesulfonamide 3. 2 and 3 were converted to the corresponding substituted trichlorosilanes 4 and 5 respectively on treatment with trichlorosilane in the presence of chloroplatinic acid. Compounds 5 reacted with methanol and pyridine to give the corresponding trimethoxysilane 6. The elemental analysis, IR, ^1H NMR and 19F NMR data of these new compounds were recorded in Table 1-4. The compounds 4, 5 can be used for the treatment of glass surface to render it water-proof and solvent-proof.     

The preparation of 3‐substituted 1,2‐benzisothiazole 1,1‐dioxides from lithiated intermediates or grignard reagents and methyl 2‐(aminosulfonyl)benzoate

A polylithiated β‐ketoester, β‐diketone, or β‐ketoamide was condensed‐cyclized with lithiated methyl 2‐(aminosulfonyl)benzoate, to afford new 3‐substituted 1,2‐benzisothiazole 1,1‐dioxides. Some Grignard or organolithium reagents were also condensed‐cyclized with methyl 2‐(aminosulfonyl)benzoate to give 3‐substituted 1,2‐benzisothiazole 1,1‐dioxides.